On Kan
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Biotechnology top 10%
- Cancer Research and Treatments
Papers in
-
- Retinal Diseases and Treatments 3
- Genetics 3
- Virus-based gene therapy research 4
- Co-authors
- Anthony David Whetton (7 shared papers)Sharifah Iqball (7 shared papers)Stephen A. Baldwin (3 shared papers)Susan M. Kingsman (3 shared papers)C M Heyworth (3 shared papers)Simon Naylor (4 shared papers)T. M. Dexter (3 shared papers)Kate E. Binley (3 shared papers)
- Journals
- The Journal of Gene Medicine (2 papers)Gene Therapy (2 papers)Growth Factors (2 papers)Human Gene Therapy (2 papers)Biochemical Society Transactions (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
On Kan
18 papers receiving 757 citations
Peers
Comparison fields: 5 of 71
- Ophthalmology 89
- Biotechnology 73
- Immunology 167
- Cancer Research 110
- Genetics 204
Countries citing papers authored by On Kan
This map shows the geographic impact of On Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by On Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites On Kan more than expected).
Fields of papers citing papers by On Kan
This network shows the impact of papers produced by On Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by On Kan. The network helps show where On Kan may publish in the future.
Co-authors
The 25 scholars most cited alongside On Kan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 180 | |
| 2 | 1990 | 106 | |
| 3 | 1994 | 103 | |
| 4 | 2005 | 81 | |
| 5 | 2005 | 77 | |
| 6 | 2006 | 49 | |
| 7 | 2001 | 42 | |
| 8 | 2009 | 39 | |
| 9 | 2002 | 29 | |
| 10 | 1991 | 20 | |
| 11 | 2007 | 17 | |
| 12 | 1994 | 15 | |
| 13 | 1991 | 13 | |
| 14 | Exploiting the hypoxia response. | 2003 | 10 |
| 15 | 2008 | 5 | |
| 16 | 2000 | 5 | |
| 17 | 1994 | 4 | |
| 18 | 1992 | 4 | |
| 19 | Evaluation of EIAV Based Lentiviral Vectors Following Ocular Delivery in the Nonhuman Primate Model: Development of RetinoStat® | 2008 | 1 |
About On Kan
On Kan is a scholar working on Ophthalmology, Genetics, Molecular Biology, Genetics and Immunology, having authored 19 papers that have together received 800 indexed citations. Recurring topics across this work include Retinal Development and Disorders (4 papers), Virus-based gene therapy research (4 papers), CRISPR and Genetic Engineering (3 papers), Retinal Diseases and Treatments (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), RNA Interference and Gene Delivery (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Ophthalmology (89 citations), Biotechnology (73 citations), Immunology (167 citations), Cancer Research (110 citations) and Genetics (204 citations). On Kan has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Anthony David Whetton, Sharifah Iqball, Stephen A. Baldwin, Susan M. Kingsman, C M Heyworth, Simon Naylor, T. M. Dexter, Kate E. Binley, Stuart Naylor and Adrian L. Harris. Their work appears in journals such as The Journal of Gene Medicine, Gene Therapy, Growth Factors, Human Gene Therapy and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.